Oseltamivir Phosphate for Oral Suspension (OSELTAMIVIR PHOSPHATE)
Oseltamivir Phosphate for Oral Suspension (OSELTAMIVIR PHOSPHATE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Oseltamivir Phosphate for Oral Suspension; Generic name: OSELTAMIVIR PHOSPHATE; Manufacturer: Oryza Pharmaceuticals Inc..
| Brand name | Oseltamivir Phosphate for Oral Suspension |
|---|---|
| Generic name | OSELTAMIVIR PHOSPHATE |
| Manufacturer | Oryza Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Oseltamivir Phosphate for Oral Suspension is an influenza neuraminidase inhibitor (NAI) indicated for: Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. ( 1.1 ) Prophylaxis of influenza A and B in patients 1 year and older. ( 1.2 ) Limitations of Use: Not a substitute for annual influenza vaccination. ( 1.3 ) Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. ( 1.3 ) Not recommended for patients with end-stage renal disease not undergoing dialysis. ( 1.3 ) 1.1 Treatment of Influenza Oseltamivir Phosphate |
| Dosage | 2 DOSAGE AND ADMINISTRATION Treatment of influenza Adults and adolescents (13 years and older): 75 mg twice daily for 5 days ( 2.2 ) Pediatric patients 1 to 12 years of age: Based on weight twice daily for 5 days ( 2.2 ) Pediatric patients 2 weeks to less than 1 year of age: 3 mg/kg twice daily for 5 days ( 2.2 ) Renally impaired adult patients (creatinine clearance >30 to 60 mL/min): Reduce to 30 mg twice daily for 5 days ( 2.4 ) Renally impaired adult patients (creatinine clearance >10 to 30 m |
| Active ingredient(s) | OSELTAMIVIR PHOSPHATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11cf45d4-0e6c-4408-bbe6-5ed94468cf2e |